Implementation Strategies for Cardiovascular Polypills
Open Access
- 17 December 2019
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 322 (23), 2279-2280
- https://doi.org/10.1001/jama.2019.18102
Abstract
This Viewpoint dispells myths that may impede potential acceptance of polypills use in treating atherosclerotic cardiovascular disease.This publication has 10 references indexed in Scilit:
- Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular DiseaseJAMA, 2019
- Polypill for Cardiovascular Disease Prevention in an Underserved PopulationThe New England Journal of Medicine, 2019
- Faculty Opinions recommendation of Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease.Published by H1 Connect ,2019
- Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trialThe Lancet, 2019
- Effect of Aspirin on Disability-free Survival in the Healthy ElderlyThe New England Journal of Medicine, 2018
- Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseasesEmergencias, 2017
- Effectiveness of fixed dose combination medication (‘polypills’) compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countriesInternational Journal of Cardiology, 2015
- Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trialsThe Lancet, 2015
- Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient dataThe Lancet, 2014
- Comparison of Risk Factor Reduction and Tolerability of a Full-Dose Polypill (With Potassium) Versus Low-Dose Polypill (Polycap) in Individuals at High Risk of Cardiovascular DiseasesCirculation: Cardiovascular Quality and Outcomes, 2012